Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
98.10    -1.40 (-1.41%)
Bid:
96.60
Ask:
98.90
Spread: 2.30 (2.381%)
Market Cap: £119.19m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Form 8.3 - Mondi Plc

26 Mar 2024 14:32

RNS Number : 3814I
Impax Asset Management Ltd
26 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Impax Asset Management Group

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Not applicable

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mondi Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Not applicable

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

GB00BMWC6P49 (EUR 0.22 ordinary)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,533,448

1.25

Not applicable

(2) Cash-settled derivatives:

Not applicable

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Not applicable

TOTAL:

5,533,448*

1.25

*Change in holding of 113 shares since the last disclosure on 25th March 2024 is in part due to the transfer out of a discretionary holding.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

EUR 0.22 ordinary

GB00BMWC6P49

Purchase

495

GBP 13.64

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

None

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

None

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

None

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

None

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

26th March 2024

Contact name:

Rose Ackerman

Telephone number*:

+44 20 3912 3033

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETEALDKADELEFA
Date   Source Headline
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSQ3 AUM update
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20253:43 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20252:16 pmRNS-RInvestor Presentation of Interim Results
22nd May 20257:01 amRNSLaunch of £10m share buyback programme
22nd May 20257:00 amRNSHalf-year Report
14th May 202512:25 pmRNS-RInvestor Presentation of Interim Results
2nd May 20257:00 amRNSNotice of Results
17th Apr 20257:00 amRNSInvestment Advisory Agreement
8th Apr 20257:00 amRNSQ2 AUM update
1st Apr 202512:29 pmRNSAcquisition of fixed income assets
27th Mar 20251:24 pmRNSHolding(s) in Company
13th Mar 20254:28 pmRNSHolding(s) in Company
6th Mar 20253:27 pmRNSHolding(s) in Company
5th Mar 20256:27 pmRNSResult of AGM
5th Mar 20257:00 amRNSAGM Statement
3rd Mar 20256:03 pmRNSHolding(s) in Company
3rd Mar 202510:58 amRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSQ1 AUM update
7th Jan 20259:17 amRNSHolding(s) in Company
17th Dec 20245:44 pmRNSHolding(s) in Company
13th Dec 20244:30 pmRNSNotice of AGM
13th Dec 20247:00 amRNSUpdate on assets under management
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20245:28 pmRNSForm 8.3 - [Renewi plc]
29th Nov 20244:30 pmRNSPublication of Annual Financial Report
28th Nov 20247:00 amRNSFinal Results
22nd Nov 20242:16 pmRNS-RInvestor Presentation of Full Year Results
20th Nov 20249:30 amRNSNotice of Results
15th Nov 20247:00 amRNSHolding(s) in Company
30th Oct 20243:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.